A new trading day began on Monday, with Bluebird bio Inc (NASDAQ: BLUE) stock price up 2.99% from the previous day of trading, before settling in for the closing price of $0.41. BLUE’s price has ranged from $0.29 to $5.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 120.02% over the last five years. Meanwhile, its annual earnings per share averaged 19.26%. With a float of $192.72 million, this company’s outstanding shares have now reached $193.92 million.
The firm has a total of 375 workers. Let’s measure their productivity. In terms of profitability, gross margin is -43.49%, operating margin of -596.15%, and the pretax margin is -565.89%.
Bluebird bio Inc (BLUE) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Bluebird bio Inc is 0.89%, while institutional ownership is 34.07%. The most recent insider transaction that took place on Sep 30 ’24, was worth 529. In this transaction an insider of this company sold 1,006 shares at a rate of $0.53, taking the stock ownership to the 170,000 shares. Before that another transaction happened on Sep 30 ’24, when Company’s President and CEO sold 34,780 for $0.53, making the entire transaction worth $18,270. This insider now owns 375,218 shares in total.
Bluebird bio Inc (BLUE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 19.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to 28.98% growth over the previous five years of trading.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Here are Bluebird bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Analysing the last 5-days average volume posted by the [Bluebird bio Inc, BLUE], we can find that recorded value of 5.69 million was lower than the volume posted last year of 7.35 million. As of the previous 9 days, the stock’s Stochastic %D was 85.61%. Additionally, its Average True Range was 0.04.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 11.15%, which indicates a significant decrease from 87.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.84% in the past 14 days, which was higher than the 98.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4480, while its 200-day Moving Average is $0.8783. Now, the first resistance to watch is $0.4325. This is followed by the second major resistance level at $0.4480. The third major resistance level sits at $0.4612. If the price goes on to break the first support level at $0.4038, it is likely to go to the next support level at $0.3906. Now, if the price goes above the second support level, the third support stands at $0.3751.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
With a market capitalization of 86.94 million, the company has a total of 194,444K Shares Outstanding. Currently, annual sales are 29,500 K while annual income is -211,910 K. The company’s previous quarter sales were 10,610 K while its latest quarter income was -60,810 K.
